Category: PD

Topline results of Phase 1-2 CDNF trial

Posted on 7 March, 2020 - Industry News

Industry news from Herantis Pharma

Phase II clinical trial of respiratory drug for treatment of Parkinson’s reveals promising results

Posted on 16 January, 2020 - Industry News, Online First

News from the Cure Parkinson’s Trust

In Parkinson’s disease, patients may suffer from delayed ON as well as wearing OFF – which is more important?

Posted on 2 June, 2015 - Sponsored Feature

Report from Britannia Pharmaceuticals on their plenary session on PD treatment, held at the 9th CONy Congress in Budapest, Hungary, March 2015

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.

WARNING

URL here

You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.

Continue

Category: PD

Topline results of Phase 1-2 CDNF trial

Phase II clinical trial of respiratory drug for treatment of Parkinson’s reveals promising results

In Parkinson’s disease, patients may suffer from delayed ON as well as wearing OFF – which is more important?

Recent News

Categories

WARNING